In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative…

“Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when…

Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available…

After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and…

Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have…

Would you please introduce The Pharmacy Guild to our readers, giving an insight in its function and its membership? We are the premium body…

We last met you in 2008 as Chair of the Pharmaceuticals Industry Council (PIC), which set itself the goal of doubling the levels of exports, R&D…

You returned to Australia a year ago after spending eight years in Europe with the company. In your view, what were the key changes in the Australian…

As a general medical practitioner with a long experience in the pharmaceutical industry including public policy, advertising, marketing and regulatory…

What impact have the PBS reforms had on sanofi-aventis in Australia? Sanofi-aventis has one of the largest portfolios of medicines in Australia,…

Would you please introduce Pretium’s specific service offerings, and the focus within these? Pretium offers a comprehensive range of integrated…

What impact have the PBS reforms had on Amgen in Australia? From a company perspective, biotechnology companies exist in a competitive space. They…